Additionally, while there were mixed reactions on the MIGS (Minimally Invasive Glaucoma Surgery) segment, the growth forecast for the iStent Infinite device remains promising. These insights have ...
Hosted on MSN1mon
Glaukos Stock Soars 59.2% Year to Date: What's Behind the Rally?The company’s flagship iStent is the first FDA-approved surgical device available for insertion in conjunction with cataract surgery ... across its international glaucoma and Corneal Health ...
Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative ... and reduced visual acuity. About iStent inject® W Trabecular Micro-Bypass System (U.S.) Indication for Use ...
Purpose: To report on the usefulness of combined Baerveldt glaucoma implantation (BGI) and scleral buckling surgery for patients with glaucoma requiring a scleral buckle for retinal detachment repair.
A comparison was made of a limbal-based (LB-BGI) versus fornix-based (FB-BGI) conjunctival flap during placement of a 350-mm 2 Baerveldt glaucoma implant (AMO, Santa Ana, CA) in subjects with at ...
Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional ... and reduced visual acuity. About iStent inject® W Trabecular Micro-Bypass System (U.S.) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback